Clinical Trials Using Fluorine F 18 4-L-fluoroglutamine (2S,4R)

Clinical trials are research studies that involve people. The clinical trials on this list are studying Fluorine F 18 4-L-fluoroglutamine (2S,4R). All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-2 of 2
  • Uptake of [18F]F-Gln during PET / CT Scan in Patients with Primary or Metastatic Breast Cancer

    This phase I trial studies the uptake of [18F]F-Gln during a positron emission tomography (PET) / computed tomography (CT) scan in patients with primary breast cancer or breast cancer that has spread to other places in the body. Glutamine is an amino acid in the body that participates in cell growth and metabolism. Dysregulation of glutamine metabolism may be associated with several malignancies. [18F]F-Gln is a specialized investigational radioactive PET tracer used to image glutamine metabolism. Imaging [18F]F-Gln uptake in various cancers may help researchers better understand the biology of tumors and determine the best way to use imaging to help study new treatments.
    Location: University of Pennsylvania / Abramson Cancer Center, Philadelphia, Pennsylvania

  • PET / CT Imaging with Fluorine F 18 4-L-Fluoroglutamine (2S,4R) in Finding Cancer

    This pilot phase I clinical trial studies how well positron emission tomography (PET) / computed tomography (CT) imaging with fluorine F 18 4-L-fluoroglutamine (2S,4R) works finding cancer. Diagnostic drugs, such as fluorine F 18 4-L-fluoroglutamine (2S,4R), may be absorbed by cancer cells. Diagnostic procedures, such as PET / CT scan, may be used to see where diagnostic drugs go in the body. PET / CT imaging with fluorine F 18 4-L-fluoroglutamine (2S,4R) may help doctors find cancer cells.
    Location: Memorial Sloan Kettering Cancer Center, New York, New York